3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N,N-dimethylimidazo[1,2-a]pyridine-6-carboxamide;3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylimidazol-4-yl)-4-methylbenzamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylpyrazol-4-yl)-4-methylbenzamide
C89H84N22O6 — CID 158054933
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N,N-dimethylimidazo[1,2-a]pyridine-6-carboxamide;3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylimidazol-4-yl)-4-methylbenzamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylpyrazol-4-yl)-4-methylbenzamide
3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N,N-dimethylimidazo[1,2-a]pyridine-6-carboxamide;3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylimidazol-4-yl)-4-methylbenzamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylpyrazol-4-yl)-4-methylbenzamide (PubChem CID 158054933) has the molecular formula C89H84N22O6 and a molecular weight of 1557.80 g/mol. Its IUPAC name is 3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N,N-dimethylimidazo[1,2-a]pyridine-6-carboxamide;3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylimidazol-4-yl)-4-methylbenzamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylpyrazol-4-yl)-4-methylbenzamide.
Molecular Properties
| Compound Name | 3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N,N-dimethylimidazo[1,2-a]pyridine-6-carboxamide;3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylimidazol-4-yl)-4-methylbenzamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylpyrazol-4-yl)-4-methylbenzamide |
|---|---|
| PubChem CID | 158054933 |
| Molecular Formula | C89H84N22O6 |
| Molecular Weight | 1557.80 g/mol |
| Exact Mass | 1556.69 |
| IUPAC Name | 3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N,N-dimethylimidazo[1,2-a]pyridine-6-carboxamide;3-[4-[5-(cyclopropylcarbamoyl)-2-methylphenyl]pyrazol-1-yl]-N-methylimidazo[1,2-a]pyridine-6-carboxamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylimidazol-4-yl)-4-methylbenzamide;N-cyclopropyl-3-(1-imidazo[1,2-a]pyridin-3-ylpyrazol-4-yl)-4-methylbenzamide |
| SMILES | CNC(=O)c1ccc2ncc(-n3cc(-c4cc(C(=O)NC5CC5)ccc4C)cn3)n2c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cn(-c2cnc3ccccn23)cn1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(=O)N(C)C)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccccn23)c1 |
| InChI | InChI=1S/C24H24N6O2.C23H22N6O2.2C21H19N5O/c1-15-4-5-16(23(31)27-19-7-8-19)10-20(15)18-11-26-30(14-18)22-12-25-21-9-6-17(13-29(21)22)24(32)28(2)3;1-14-3-4-15(23(31)27-18-6-7-18)9-19(14)17-10-26-29(13-17)21-11-25-20-8-5-16(12-28(20)21)22(30)24-2;1-14-5-6-15(21(27)24-17-7-8-17)10-18(14)16-11-23-26(13-16)20-12-22-19-4-2-3-9-25(19)20;1-14-5-6-15(21(27)24-16-7-8-16)10-17(14)18-12-25(13-23-18)20-11-22-19-4-2-3-9-26(19)20/h4-6,9-14,19H,7-8H2,1-3H3,(H,27,31);3-5,8-13,18H,6-7H2,1-2H3,(H,24,30)(H,27,31);2-6,9-13,17H,7-8H2,1H3,(H,24,27);2-6,9-13,16H,7-8H2,1H3,(H,24,27) |
| InChIKey | FJXSWCYKTSDIBN-UHFFFAOYSA-N |
| XLogP | 12.61 |
| TPSA | 306.29 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 117 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1557.80 |
| LogP ≤ 5 | 12.61 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158054933 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.